(1)
S, M.; KUMAR M, K. PERSPECTIVES OF CLINICAL EXPERTS ON THE CURRENT USAGE PATTERNS AND THE PREFERENCE OF VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES. Innovare J Med Sci 2024, 12, 1-3.